Frankfurt - Delayed Quote EUR
Maravai LifeSciences Holdings, Inc. (MAR.F)
1.8100
+0.0100
+(0.56%)
As of 8:05:02 AM GMT+2. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
259,185
259,185
288,945
883,001
799,240
Cost of Revenue
150,876
150,876
148,743
168,957
140,561
Gross Profit
108,309
108,309
140,202
714,044
658,679
Operating Expense
180,992
180,992
168,670
147,628
115,283
Operating Income
-72,683
-72,683
-28,468
566,416
543,396
Net Non Operating Interest Income Expense
-20,297
-20,297
-18,165
-18,076
-30,260
Other Income Expense
-168,502
-168,502
664,369
3,132
17,629
Pretax Income
-261,482
-261,482
617,736
551,472
530,765
Tax Provision
-1,860
-1,860
756,111
60,809
61,515
Net Income Common Stockholders
-144,846
-144,846
-119,029
220,205
182,037
Average Dilution Earnings
--
--
--
206,071
220,319
Diluted NI Available to Com Stockholders
-144,846
-144,846
-119,029
426,276
402,356
Basic EPS
-1.67
-1.05
-0.90
1.67
1.59
Diluted EPS
-1.67
-1.05
-0.90
1.67
1.56
Basic Average Shares
135,481.5000
137,906
131,919
131,545
114,791
Diluted Average Shares
135,481.5000
137,906
131,919
255,323
257,803
Total Operating Income as Reported
-235,617
-235,617
-31,648
574,216
554,645
Total Expenses
331,868
331,868
317,413
316,585
255,844
Net Income from Continuing & Discontinued Operation
-144,846
-144,846
-119,029
220,205
182,037
Normalized Income
20,093.3314
20,093.3314
-116,516.8000
213,448.1200
172,091.7450
Interest Income
27,403
27,403
27,727
2,338
--
Interest Expense
47,700
47,700
45,892
20,414
30,260
Net Interest Income
-20,297
-20,297
-18,165
-18,076
-30,260
EBIT
-213,782
-213,782
663,628
571,886
561,025
EBITDA
-156,917
-156,917
712,409
609,989
594,569
Reconciled Cost of Revenue
150,876
150,876
148,743
168,957
140,561
Reconciled Depreciation
56,865
56,865
48,781
38,103
33,544
Net Income from Continuing Operation Net Minority Interest
-144,846
-144,846
-119,029
220,205
182,037
Total Unusual Items Excluding Goodwill
-166,121
-166,121
-3,180
7,592
11,249
Total Unusual Items
-166,121
-166,121
-3,180
7,592
11,249
Normalized EBITDA
9,204
9,204
715,589
602,397
583,320
Tax Rate for Calcs
0
0
0.0002
0.0001
0.0001
Tax Effect of Unusual Items
-1,181.6686
-1,181.6686
-667.8000
835.1200
1,303.7450
12/31/2021 - 5/14/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
141080.KQ LigaChem Biosciences Inc.
111,500.00
-1.68%
2171.HK CARsgen Therapeutics Holdings Limited
15.400
-1.91%
2142.HK HBM Holdings Limited
8.210
+3.40%
2696.HK Shanghai Henlius Biotech, Inc.
37.850
-2.82%
1530.HK 3SBIO
13.020
-2.69%
9606.HK Duality Biotherapeutics, Inc.
207.400
-7.82%
207940.KS Samsung Biologics Co.,Ltd.
1,035,000.00
-1.05%
9995.HK RemeGen Co., Ltd.
43.450
+5.08%
DNTH Dianthus Therapeutics, Inc.
21.23
-1.53%
1672.HK ASCLETIS-B
6.280
-6.69%